Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125902941 | 12590294 | 1 | I | 20151005 | 20160725 | 20160725 | EXP | CA-PFIZER INC-2015336939 | PFIZER | 0.00 | A | F | Y | 0.00000 | 20160725 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125902941 | 12590294 | 1 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 0 | 50 | MG | /wk | |||||||
| 125902941 | 12590294 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | UNK | U | 11719 | |||||||||
| 125902941 | 12590294 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | U | UNK | 7073 | ||||||||
| 125902941 | 12590294 | 4 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 300 MG, EVERY 6 WEEKS | U | 0 | 300 | MG | |||||||
| 125902941 | 12590294 | 5 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | U | UNK | 0 | TABLET | |||||||
| 125902941 | 12590294 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 125902941 | 12590294 | 7 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | UNK | U | UNK | 0 | ||||||||
| 125902941 | 12590294 | 8 | SS | GOLD | GOLD | 1 | Unknown | UNK | U | 0 | |||||||||
| 125902941 | 12590294 | 9 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | UNK | U | 0 | CAPSULE | ||||||||
| 125902941 | 12590294 | 10 | SS | HUMIRA | ADALIMUMAB | 1 | 40 MG, EVERY 2 WEEKS | UNK | 0 | 40 | MG | ||||||||
| 125902941 | 12590294 | 11 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 640 MG, EVERY 4 WEEKS | U | UNK | 0 | 640 | MG | ||||||
| 125902941 | 12590294 | 12 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | 200 MG, QWK | UNK | 0 | 200 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125902941 | 12590294 | 1 | Rheumatoid arthritis |
| 125902941 | 12590294 | 2 | Rheumatoid arthritis |
| 125902941 | 12590294 | 3 | Rheumatoid arthritis |
| 125902941 | 12590294 | 4 | Rheumatoid arthritis |
| 125902941 | 12590294 | 5 | Rheumatoid arthritis |
| 125902941 | 12590294 | 6 | Rheumatoid arthritis |
| 125902941 | 12590294 | 7 | Rheumatoid arthritis |
| 125902941 | 12590294 | 8 | Rheumatoid arthritis |
| 125902941 | 12590294 | 9 | Rheumatoid arthritis |
| 125902941 | 12590294 | 10 | Rheumatoid arthritis |
| 125902941 | 12590294 | 11 | Rheumatoid arthritis |
| 125902941 | 12590294 | 12 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125902941 | 12590294 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125902941 | 12590294 | Blood iron abnormal | |
| 125902941 | 12590294 | Disease progression | |
| 125902941 | 12590294 | Drug ineffective | |
| 125902941 | 12590294 | Drug intolerance | |
| 125902941 | 12590294 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125902941 | 12590294 | 1 | 200208 | 200505 | 0 | |
| 125902941 | 12590294 | 4 | 200509 | 200701 | 0 | |
| 125902941 | 12590294 | 10 | 200701 | 201006 | 0 | |
| 125902941 | 12590294 | 11 | 201103 | 0 | ||
| 125902941 | 12590294 | 12 | 201007 | 201103 | 0 |